You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
神州細胞(688520.SH)將於6月22日上市 預計上半年歸母淨虧損約3.08億-3.24億元
格隆匯 06-18 19:42

格隆匯 6 月 18日丨神州細胞(688520.SH)發佈首次公開發行股票科創板上市公告書,發行股份數量為5000萬股,佔此次發行後總股本的11.49%,全部為公司公開發行新股;發行價為25.64/股;將於2020622日在上海證券交易所上市

經發行人初步測算,預計20201-6月營業收入約為16萬元至17萬元,同比下降90.61%91.16%;預計發生期間費用約為31188萬元至34603萬元,同比下降23.77%31.29%;預計20201-6月期間淨虧損約30823萬元至32482萬元,較上年同期減少淨虧損10574萬元至12233萬元;預計實現歸屬於母公司股東的淨虧損約30761萬元至32417萬元,較上年同期減少淨虧損10415萬元至12071萬元;預計實現扣除非經常性損益後屬於母公司股東的淨虧損約為32081萬元33790萬元,較上年同期增加淨虧損4214萬元至5923萬元

發行人2020年上半年持續虧損,近兩年,隨着發行人研發規模的擴大,在研產品進入臨牀試驗階段,臨牀試驗進度持續推進,導致研發投入大幅增加。20201-6月,受新型冠狀病毒肺炎疫情的影響相關臨牀試驗進度放緩,預計研發投入增幅有所放緩。綜上,預計20201-6月發行人經營情況平穩,不存在異常變化。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account